ConductScience.org, home

Comparison · NCT03407625-98a7b491

Foley Bulb Plus Oral Misoprostol vs Oral Misoprostol: Number of Participants With Postpartum Fever

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. Foley Bulb Plus Oral Misoprostol vs Oral Misoprostol: Number of Participants With Postpartum Fever. Trial comparisons, record NCT03407625-98a7b491. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT03407625-98a7b491

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.009850.005510.0175wilson
Risk in group 20.00270.000920.00792wilson
Risk difference, group 1 minus group 20.007150.0003620.015newcombe hybrid score
Risk ratio, group 1 over group 23.641.0213log
Odds ratio, group 1 over group 23.671.0213.2log
Number needed to treat, for one more participant with the outcome on Foley Bulb Plus Oral Misoprostol than on Oral Misoprostol14066.52,770from the risk difference interval

Groups2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1Foley Bulb Plus Oral Misoprostol
Patients will received initial transcervical foley bulb, followed by oral misoprostol 100 micrograms given every 4 hours for a maximum of 2 doses.~Foley bulb plus Oral Misoprostol: Although labeled experimental for comparison purposes, this is not an experimental intervention, as the method is a currently accepted standard of care for cervical ripening and labor induction in the United States.
111,117OG000
Group 2Oral Misoprostol
Patients will receive oral misoprostol 100 micrograms given every 4 hours for a maximum of 2 doses.~Oral Misoprostol: Patients will receive standard oral misoprostol 100mcg according to current Labor Induction Protocol.
31,110OG001

Outcome

Type
SECONDARY
Title
Number of Participants With Postpartum Fever
Description
Fever recorded in the time after delivery but prior to discharge from the hospital, with clinical assessment of endometritis
Time frame
Following delivery and prior to discharge
Population

Source ClinicalTrials.gov

Trial

Title
Foley Bulb With Oral Misoprostol for Induction of Labor
NCT number
NCT03407625
Phases
NA
Conditions
Pregnancy, Labor, Induced
Interventions
Foley bulb plus Oral Misoprostol, Oral Misoprostol
Lead sponsor
University of Texas Southwestern Medical Center
Results first posted
2020-11-04

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT03407625-98a7b491